Vir Biotechnology (VIR) PT Lowered to $59 at Goldman Sachs
Tweet
Share
E-mailGet Alerts VIR Hot Sheet
Price: $9.24 +2.67%
Rating Summary:
10 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
10 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Goldman Sachs analyst Paul Choi lowered the price target on Vir Biotechnology (NASDAQ: VIR) to $59.00 (from $61.00) while maintaining a Buy rating.
You May Also Be Interested In
- H.C. Wainwright Reiterates Buy Rating on Vir Biotechnology (VIR)
- Solar Industries (SOIL:IN) PT Raised to INR23,500 at ICICI Securities
- Honasa Consumer Ltd (HONASA:IN) PT Raised to INR720 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
